Forte Biosciences, Inc.FBRXNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank80
3Y CAGR+12.1%
5Y CAGR+22.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+12.1%/yr
vs -10.3%/yr prior
5Y CAGR
+22.6%/yr
Recent deceleration
Acceleration
+22.3pp
Accelerating
Percentile
P80
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.69M | -24.0% |
| 2024 | $15.37M | +44.8% |
| 2023 | $10.62M | +27.9% |
| 2022 | $8.30M | +8.8% |
| 2021 | $7.63M | +80.8% |
| 2020 | $4.22M | +205.9% |
| 2019 | $1.38M | -89.2% |
| 2018 | $12.81M | +55.0% |
| 2017 | $8.27M | +93.7% |
| 2016 | $4.27M | - |